Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN Poll

 More »
Jan 31, 2012

Therapeutics for Rare and Neglected Diseases

How helpful do you think TRND will prove in stimulating development of drugs for rare and neglected diseases?

Very
 
  50.0%
Somewhat
 
  25.0%
Not Much
 
  18.8%
Undecided
 
  6.3%

Suggest a Poll
More Polls » View Results »

NIH’s current budget sets aside $24 million for its Therapeutics for Rare and Neglected Diseases (TRND) program, the same as every year since the program began in 2009. While NIH has tried but failed to bump up TRND spending to $50 million this fiscal year and last, the agency brought the program under its new translational science center, ending years of relying on assessments cobbled together from existing institutes and centers. TRND has grown to 14 projects, which includes four pilot projects. A new solicitation for projects is expected to come out later this year. Do you think TRND has what it takes to improve R&D for drugs to treat orphan diseases and neglected diseases?

Related Content

GEN News Highlights

MORE RELATED GEN NEWS HIGHLIGHTS

Insight & Intelligence™

MORE RELATED INSIGHT & INTELLIGENCE™

GEN Articles

MORE RELATED GEN ARTICLES

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

GEN’s Hall of Shame

Will you be voting for any of the candidates on GEN’s Hall of Shame list in the next election?

Suggest a Poll